Table 1 Baseline Characteristics of the Patients at the initiation of amiodarone infusion
Variable | Amiodarone treated patients (n = 46) |
|---|---|
Age (year) | 59.8 ± 11.3a |
Sex (male) | 23(50.0)b |
BMI (kg/m2) | 27.4 ± 3.2 |
SOFA SCORE | 7.24 ± 1.8 |
PLT (103/μl) | 229.9 ± 85.1 |
BSA (m2) | 1.93 ± 0.15 |
HR (bpm) | 118.9 ± 18.7 |
MAP (mmHg) | 98.4 ± 9.3 |
CI (l/min/m2) | 3.61 ± 0.94 |
SVR (dynes/seconds/cm−5) | 1106.8 ± 381.6 |
SVI (ml/m2/beat) | 31.03 ± 8.5 |
NE (μ/min) | 10.74 ± 2.9 |
FTC (milliseconds) | 356.9 ± 78.6 |
LACTAT (mg/dL) | 24.6 ± 11.5 |
Comorbidities n (%) | |
Heart failure | 10 (21%) |
Diabetes mellitus | 18 (39.1%) |
Chronic kidney disease | 13 (28.2%) |
Previous MI | 12 (26%) |
Previous stroke | 9 (19%) |
Chronic obstructive pulmonary disease | 1 (2.2%) |
CRP | 13.13 ± 10.59 |
GFR (mL/min/1.73 m2) | 78.43 ± 16.56 |
Cirrhosis | 3 (6.5%) |